Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Oncotarget|May 19, 2015
Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagyHaiyan Zhai, Andrew Fesler, Yufeng Ba, et al.
Cancer Translational Medicine|July 28, 2017
Autophagy regulated by miRNAs in colorectal cancer progression and resistanceAndrew Fesler, Hua Liu, Ning Wu, et al.
Clinical Colorectal Cancer|September 10, 2013
Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancerHaiyan Zhai, Andrew Fesler, Kristina Schee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2022
Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeuticsJohn G Yuen, Andrew Fesler, Ga-Ram Hwang, et al.
Oncotarget|August 20, 2015
Identification of miR-215 mediated targets/pathways via translational immunoprecipitation expression analysis (TrIP-chip)Andrew Fesler, Xiao Xu, Xiao Zheng, et al.
Molecular Therapy Oncolytics|March 13, 2023
Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancerGa-Ram Hwang, John G Yuen, Andrew Fesler, et al.
Molecular Therapy. Oncology|April 10, 2024
Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinomaJohn G Yuen, Ga-Ram Hwang, Andrew Fesler, et al.
Oncotarget|September 9, 2017
Expression analysis of microRNA as prognostic biomarkers in colorectal cancerJie Yang, Dongling Ma, Andrew Fesler, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Development of Gemcitabine-Modified miRNA Mimics as Cancer Therapeutics for Pancreatic Ductal AdenocarcinomaJohn G Yuen, Ga-Ram Hwang, Andrew Fesler, et al.
Cancers|March 13, 2024
Correction: Soung et al. Therapeutic Potential of Chemically Modified MiR-489 in Triple-Negative Breast Cancers. Cancers 2020, 12, 2209Young Hwa Soung, Heesung Chung, Cecilia Yan, et al.
Pageof 3